Related Experiment Videos
The damaging role of bacteria in chronic lung infection
1Host Defence Unit, Imperial College at National Heart and Lung Institute, Royal Brompton Hospital, London, UK.
Abstract:
Because of their embryological derivation from foregut the respiratory airways are regularly host to bacteria arriving in inspired air and aspirated from the naso-oropharynx. Should the first-line defence (mucociliary clearance) be less than perfect, such bacteria remain longer in the airway mucus and some are able to capitalize on this delay by compromising mucus transport further through the production of epithelium-damaging cilioinhibitory and ciliotoxic substances. Bacterial persistence in the airways elicits an inflammatory host response which causes further damage to the airway and results in a 'vicious circle' of progressive lung damage. Treatment hinges upon eliminating the bacteria in the mucus using antibiotics that penetrate mucus well (e.g. fluoroquinolones)--and considering adjunct therapy with anti-inflammatory and mucokinetic agents.
Insights
Respiratory airways can harbor bacteria, leading to a cycle of lung damage. Effective treatment involves antibiotics that penetrate mucus and potentially anti-inflammatory and mucokinetic agents to break this cycle.
Area of Science:
- Pulmonary Medicine
- Microbiology
- Immunology
Background:
- Respiratory airways are embryologically derived from the foregut, making them susceptible to bacterial colonization from inspired air and naso-oropharyngeal aspiration.
- Impaired mucociliary clearance allows bacteria to persist in airway mucus, initiating a damaging cycle.
- Bacterial persistence triggers an inflammatory host response, exacerbating airway damage and leading to progressive lung injury.
Purpose of the Study:
- To elucidate the mechanisms of bacterial persistence in respiratory airways.
- To identify therapeutic strategies for managing bacterial-induced lung damage.
Main Methods:
- The study reviews the pathophysiology of bacterial colonization and host response in the respiratory tract.
- It discusses the role of mucociliary clearance and bacterial factors in disease progression.
- Treatment strategies involving antibiotics and adjunct therapies are considered.
Main Results:
- Bacteria in airway mucus can compromise mucus transport by producing epithelium-damaging substances.
- Bacterial persistence leads to a 'vicious circle' of inflammation and progressive lung damage.
- Antibiotics with good mucus penetration, such as fluoroquinolones, are crucial for treatment.
Conclusions:
- Eliminating bacteria from airway mucus is key to interrupting the cycle of lung damage.
- Adjunct therapies, including anti-inflammatory and mucokinetic agents, may complement antibiotic treatment.
- Understanding the interplay between bacteria, mucus, and host response is vital for effective management of airway diseases.